SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-029161
Filing Date
2023-08-16
Accepted
2023-08-16 16:16:02
Documents
82
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1362136
2 ex31-1.htm EX-31.1 10024
3 ex31-2.htm EX-31.2 10019
4 ex32-1.htm EX-32.1 4508
5 ex32-2.htm EX-32.2 4541
  Complete submission text file 0001493152-23-029161.txt   7030939

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20230630.xsd EX-101.SCH 53512
7 XBRL CALCULATION FILE vvos-20230630_cal.xml EX-101.CAL 67756
8 XBRL DEFINITION FILE vvos-20230630_def.xml EX-101.DEF 209303
9 XBRL LABEL FILE vvos-20230630_lab.xml EX-101.LAB 384377
10 XBRL PRESENTATION FILE vvos-20230630_pre.xml EX-101.PRE 326520
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1235644
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39796 | Film No.: 231178401
SIC: 3841 Surgical & Medical Instruments & Apparatus